Picture of SOL-GEL TECHNOLOGIES logo

SLGL — SOL-GEL TECHNOLOGIES News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Sol-Gel Technologies Reports Second Quarter 2022 Financial Results

Aug 4 (Reuters) - Sol Gel Technologies Ltd  SLGL.O :
    * SOL-GEL TECHNOLOGIES REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 REVENUE $3.5 MILLION VERSUS $900,000
    * RECEIVES $3.5 MILLION MILESTONE PAYMENT FROM COMMERCIAL
PARTNER
GALDERMA HOLDING SA ("GALDERMA") FOR FDA APPROVAL OF EPSOLAY
    * CASH RUNWAY EXPECTED TO EXTEND THROUGH END OF 2023
    * QTRLY LOSS PER SHARE $0.53
    * Q2 EARNINGS PER SHARE VIEW $-0.10, REVENUE VIEW $4.6
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX60lGgc 
Further company coverage:  SLGL.O

Recent news on SOL-GEL TECHNOLOGIES

See all news